These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24980867)

  • 1. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice.
    Li W; Deng G; Li M; Zeng J; Zhao L; Liu X; Wang Y
    Mol Immunol; 2014 Nov; 62(1):86-95. PubMed ID: 24980867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-Fusion Protein Complexes Protect against Mycobacterium tuberculosis Infection.
    Hart P; Copland A; Diogo GR; Harris S; Spallek R; Oehlmann W; Singh M; Basile J; Rottenberg M; Paul MJ; Reljic R
    Mol Ther; 2018 Mar; 26(3):822-833. PubMed ID: 29518353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multistage protein subunit vaccine as BCG-booster confers protection against Mycobacterium tuberculosis infection in murine models.
    Chen Z; Zhang Y; Wu J; Xu J; Hu Z; Fan XY
    Int Immunopharmacol; 2024 Sep; 139():112811. PubMed ID: 39068754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Pichinde viral vector expressing tuberculosis antigens elicits strong T cell responses and protection in mice.
    Kirk NM; Huang Q; Vrba S; Rahman M; Block AM; Murphy H; White DW; Namugenyi SB; Ly H; Tischler AD; Liang Y
    Front Immunol; 2023; 14():1127515. PubMed ID: 36845108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose Ag85B-ESAT6-loaded poly(lactic-
    Malik A; Gupta M; Mani R; Bhatnagar R
    Int J Nanomedicine; 2019; 14():3129-3143. PubMed ID: 31118627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic profiling of Mycobacterium tuberculosis Rv1513 reveals its ability to switch on Th1 based immunity.
    Shi Z; Zhou L; Wang X; Zhang Z; Kong L; Zhang Y
    Arch Microbiol; 2024 Jul; 206(8):352. PubMed ID: 39012499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium tuberculosis antigen 85B modifies BCG-induced antituberculosis immunity and favors pathogen survival.
    Piccaro G; Aquino G; Gigantino V; Tirelli V; Sanchez M; Iorio E; Matarese G; Cassone A; Palma C
    J Leukoc Biol; 2024 May; 115(6):1053-1069. PubMed ID: 38242866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal boosting with MVA encoding secreted mycobacterial proteins Ag85A and ESAT-6 generates strong pulmonary immune responses and protection against M. tuberculosis in mice given BCG as neonates.
    Khanna M; Rady H; Dai G; Ramsay AJ
    Vaccine; 2021 Mar; 39(12):1780-1787. PubMed ID: 33632562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel multistage antigens ERA005f confer protection against
    Fan X; Zhao X; Wang R; Li M; Luan X; Wang R; Wan K; Liu H
    Front Immunol; 2023; 14():1276887. PubMed ID: 38022539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ag85B with c-di-AMP as mucosal adjuvant showed immunotherapeutic effects on persistent Mycobacterium tuberculosis infection in mice.
    Liang X; Cui R; Li X; Ning H; Kang J; Lu Y; Zhou S; Huang X; Peng Y; Zhang J; Li S; Ma Y; Bai Y
    Braz J Med Biol Res; 2024; 57():e13409. PubMed ID: 38958367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological properties and protective efficacy of a single mycobacterial antigen displayed on polyhydroxybutyrate beads.
    Rubio-Reyes P; Parlane NA; Buddle BM; Wedlock DN; Rehm BHA
    Microb Biotechnol; 2017 Nov; 10(6):1434-1440. PubMed ID: 28714174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.
    Coppola M; van den Eeden SJF; Robbins N; Wilson L; Franken KLMC; Adams LB; Gillis TP; Ottenhoff THM; Geluk A
    Front Immunol; 2018; 9():308. PubMed ID: 29535713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The
    Mishra A; Khan A; Singh VK; Glyde E; Saikolappan S; Garnica O; Das K; Veerapandian R; Dhandayuthapani S; Jagannath C
    Front Immunol; 2024; 15():1321657. PubMed ID: 38975346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.
    Scriba TJ; Tameris M; Mansoor N; Smit E; van der Merwe L; Isaacs F; Keyser A; Moyo S; Brittain N; Lawrie A; Gelderbloem S; Veldsman A; Hatherill M; Hawkridge A; Hill AV; Hussey GD; Mahomed H; McShane H; Hanekom WA
    Eur J Immunol; 2010 Jan; 40(1):279-90. PubMed ID: 20017188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and Evaluation of Ag85B:HspX:hFcγ1 Immunogenicity as an Fc Fusion Recombinant Multi-Stage Vaccine Candidate Against Mycobacterium tuberculosis.
    Karbalaei M; Mosavat A; Soleimanpour S; Farsiani H; Ghazvini K; Amini AA; Sankian M; Rezaee SA
    Curr Microbiol; 2024 Apr; 81(5):127. PubMed ID: 38575759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosis.
    Reba SM; Li Q; Onwuzulike S; Ding X; Karim AF; Hernandez Y; Fulton SA; Harding CV; Lancioni CL; Nagy N; Rodriguez ME; Wearsch PA; Rojas RE
    Eur J Immunol; 2014 May; 44(5):1410-21. PubMed ID: 24497180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Response to the Recombinant Apa Protein from Mycobacterium tuberculosis Expressed in Streptomyces lividans After Intranasal Administration in Mice. Induction of Protective Response to Tubercle Bacillus Aerosols Exposure.
    Martínez-Sotelo JA; Vallecillo AJ; Parada C; Segura E; Campuzano J; Silva-Miranda M; Servín-González L; Espitia C
    Curr Microbiol; 2024 May; 81(7):197. PubMed ID: 38816607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium nanoparticles enhance mucosal immunity against Mycobacterium bovis infection.
    Ge X; Liang Z; Li K; Dong Y; Wang Y; Liu Y; Liu Z; Wang H; Nan Y; Chen S; Li L; Guo Y; Zhou X
    Int Immunopharmacol; 2024 Aug; 137():112384. PubMed ID: 38878484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fbpA/sapM double knock out strain of Mycobacterium tuberculosis is highly attenuated and immunogenic in macrophages.
    Saikolappan S; Estrella J; Sasindran SJ; Khan A; Armitige LY; Jagannath C; Dhandayuthapani S
    PLoS One; 2012; 7(5):e36198. PubMed ID: 22574140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immunoinformatics-Based Study of Mycobacterium tuberculosis Region of Difference-2 Uncharacterized Protein (Rv1987) as a Potential Subunit Vaccine Candidate for Preliminary Ex Vivo Analysis.
    Arega AM; Dhal AK; Pattanaik KP; Nayak S; Mahapatra RK
    Appl Biochem Biotechnol; 2024 Apr; 196(4):2367-2395. PubMed ID: 37498378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.